25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Bischoff A, Frischer J, Knod JL, Dickie B, Levitt MA, Holder M, Jackson L, Peña A. Damaged anal canal as a cause of fecal incontinence after surgical repair for Hirschsprung disease - a preventable and under-reported complication. Journal of Pediatric Surgery. PMID 27624566 DOI: 10.1016/J.Jpedsurg.2016.08.027  0.306
2016 Knod JL, Holder M, Cortez AR, Martinez-Leo B, Kern P, Saeed S, Warner B, Dickie B, Falcone RA, von Allmen D, Frischer JS. Surgical outcomes, bowel habits and quality of life in young patients after ileoanal anastomosis for ulcerative colitis. Journal of Pediatric Surgery. PMID 27417342 DOI: 10.1016/J.Jpedsurg.2016.03.002  0.301
2015 Knod JL, Crawford K, Dusing M, Collins MH, Chernoguz A, Frischer JS. Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 26530519 DOI: 10.1007/S11605-015-3002-1  0.339
2015 Knod JL, Crawford K, Dusing M, Frischer JS. Murine colitis treated with multitargeted tyrosine kinase inhibitors. The Journal of Surgical Research. PMID 26521099 DOI: 10.1016/J.Jss.2015.09.023  0.354
2014 Bischoff A, Frischer J, Dickie BH, Peña A. Anorectal malformation without fistula: a defect with unique characteristics. Pediatric Surgery International. 30: 763-6. PMID 24969816 DOI: 10.1007/S00383-014-3527-5  0.304
2014 Knod JL, Crawford K, Dusing M, Frischer JS. Mouse strain influences angiogenic response to dextran sodium sulfate-induced colitis Journal of Surgical Research. 190: 47-54. PMID 24793451 DOI: 10.1016/J.Jss.2014.04.009  0.312
2013 Keswani SG, Balaji S, Le LD, Leung A, Parvadia JK, Frischer J, Yamano S, Taichman N, Crombleholme TM. Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 21: 554-62. PMID 23758212 DOI: 10.1111/Wrr.12065  0.334
2013 Knod L, Donovan EC, Chernoguz A, Crawford KM, Dusing MR, Frischer JS. Vascular endothelial growth factor receptor-2 inhibition in experimental murine colitis. The Journal of Surgical Research. 184: 101-7. PMID 23688787 DOI: 10.1016/J.Jss.2013.04.026  0.367
2013 Currier MA, Eshun FK, Sholl A, Chernoguz A, Crawford K, Divanovic S, Boon L, Goins WF, Frischer JS, Collins MH, Leddon JL, Baird WH, Haseley A, Streby KA, Wang PY, et al. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1014-23. PMID 23481323 DOI: 10.1038/Mt.2013.39  0.302
2013 Knod JL, Crawford KM, Dusing MR, Chernoguz A, Collins MH, Frischer J. 206 Link Between VEGF Expression, Angiogenesis and Inflammation in Pediatric Crohn's Disease Gastroenterology. 144: S-1046-S-1047. DOI: 10.1016/S0016-5085(13)63890-1  0.333
2013 Knod J, Frischer J, Donovan E, Dusing M, Crawford K, Chernoguz A. Vascular Endothelial Growth Factor Receptor-2 Inhibition in a Model of Murine Colitis Journal of Surgical Research. 179: 339. DOI: 10.1016/J.Jss.2012.10.770  0.333
2012 Chernoguz A, Crawford K, Vandersall A, Rao M, Willson T, Denson LA, Frischer JS. Pretreatment with anti-VEGF therapy may exacerbate inflammation in experimental acute colitis. Journal of Pediatric Surgery. 47: 347-54. PMID 22325388 DOI: 10.1016/J.Jpedsurg.2011.11.028  0.35
2012 Chernoguz A, Crawford K, Donovan E, Vandersall A, Berglund C, Cripe TP, Frischer JS. EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model. The Journal of Surgical Research. 173: 1-9. PMID 21658718 DOI: 10.1016/J.Jss.2011.04.041  0.341
2011 Chernoguz A, Donovan E, Crawford K, Vandersall A, Frischer J. Monotherapy with a selective EGFR inhibitor, gefitinib, fails to suppress vascular proliferation and tumor growth in a murine model of Ewing's sarcoma Journal of Surgical Research. 165: 176. DOI: 10.1016/J.Jss.2010.11.773  0.309
2010 Lawal TA, Frischer JS, Falcone RA, Chatoorgoon K, Denson LA, Levitt MA. The transanal approach with laparoscopy or laparotomy for the treatment of rectal strictures in Crohn's disease. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 20: 791-5. PMID 20874230 DOI: 10.1089/Lap.2009.0470  0.313
2010 Bischoff A, Gupta A, D'Mello S, Mezoff A, Podberesky D, Barnett S, Keswani S, Frischer JS. Crohn's disease limited to the appendix: a case report in a pediatric patient. Pediatric Surgery International. 26: 1125-8. PMID 20714732 DOI: 10.1007/S00383-010-2689-Z  0.319
2008 Kadenhe-Chiweshe A, Papa J, McCrudden KW, Frischer J, Bae JO, Huang J, Fisher J, Lefkowitch JH, Feirt N, Rudge J, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Molecular Cancer Research : McR. 6: 1-9. PMID 18234958 DOI: 10.1158/1541-7786.Mcr-07-0101  0.362
2006 Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Glade Bender J, Kandel JJ, Yamashiro DJ. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Research. 66: 4378-84. PMID 16618763 DOI: 10.1158/0008-5472.Can-05-3810  0.349
2004 Frischer JS, Huang J, Serur A, Kadenhe-Chiweshe A, McCrudden KW, O'Toole K, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature International Journal of Oncology. 25: 549-553. PMID 15289855 DOI: 10.3892/Ijo.25.3.549  0.343
2004 Frischer JS, Huang J, Serur A, Kadenhe A, Yamashiro DJ, Kandel JJ. Biomolecular markers and involution of hemangiomas. Journal of Pediatric Surgery. 39: 400-4. PMID 15017560 DOI: 10.1016/J.Jpedsurg.2003.11.043  0.345
2003 Kaicker S, McCrudden KW, Beck L, New T, Huang J, Frischer JS, Serur A, Kadenhe-Chiweshe A, Yokoi A, Kandel JJ, Yamashiro DJ. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma International Journal of Oncology. 23: 1651-1655. PMID 14612937 DOI: 10.3892/Ijo.23.6.1651  0.341
2003 Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, Otoole K, Yamashiro DJ, Kandel JJ. Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor Oncology Reports. 10: 1271-1274. PMID 12883692 DOI: 10.3892/Or.10.5.1271  0.311
2003 Huang J, Frischer JS, Serur A, Kadenhe A, Yokoi A, McCrudden KW, New T, O'Toole K, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proceedings of the National Academy of Sciences of the United States of America. 100: 7785-90. PMID 12805568 DOI: 10.1073/Pnas.1432908100  0.361
2003 McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W, Grosfeld J, Gittes G, Chochat S. Anti-VEGF antibody in experimental hepatoblastoma: Suppression of tumor growth and altered angiogenesis Journal of Pediatric Surgery. 38: 308-314. PMID 12632340 DOI: 10.1053/Jpsu.2003.50099  0.363
2002 Kim ES, Serur A, Huang J, Manley CA, McCrudden KW, Frischer JS, Soffer SZ, Ring L, New T, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America. 99: 11399-404. PMID 12177446 DOI: 10.1073/Pnas.172398399  0.358
Show low-probability matches.